China · Delayed Price · Currency is CNY Jianerkang Medical Statistics
Total Valuation
SHA:603205 has a market cap or net worth of CNY 3.39 billion. The enterprise value is 2.61 billion.
| Market Cap | 3.39B |
| Enterprise Value | 2.61B |
Important Dates
The next confirmed earnings date is Thursday, October 29, 2026.
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Jul 9, 2026 |
Share Statistics
SHA:603205 has 156.00 million shares outstanding. The number of shares has increased by 26.09% in one year.
| Current Share Class | 156.00M |
| Shares Outstanding | 156.00M |
| Shares Change (YoY) | +26.09% |
| Shares Change (QoQ) | +6.60% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.22% |
| Float | n/a |
Valuation Ratios
The trailing PE ratio is 30.22.
| PE Ratio | 30.22 |
| Forward PE | n/a |
| PS Ratio | 3.23 |
| PB Ratio | 2.25 |
| P/TBV Ratio | 2.34 |
| P/FCF Ratio | 47.25 |
| P/OCF Ratio | 20.83 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.20, with an EV/FCF ratio of 36.36.
| EV / Earnings | 22.95 |
| EV / Sales | 2.48 |
| EV / EBITDA | 14.20 |
| EV / EBIT | 19.34 |
| EV / FCF | 36.36 |
Financial Position
The company has a current ratio of 5.67, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.67 |
| Quick Ratio | 4.70 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.10 |
| Debt / FCF | 0.25 |
| Interest Coverage | 84.51 |
Financial Efficiency
Return on equity (ROE) is 7.75% and return on invested capital (ROIC) is 15.93%.
| Return on Equity (ROE) | 7.75% |
| Return on Assets (ROA) | 4.94% |
| Return on Invested Capital (ROIC) | 15.93% |
| Return on Capital Employed (ROCE) | 8.69% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 620,657 |
| Profits Per Employee | 67,149 |
| Employee Count | 1,694 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 4.38 |
Taxes
In the past 12 months, SHA:603205 has paid 15.10 million in taxes.
| Income Tax | 15.10M |
| Effective Tax Rate | 11.72% |
Stock Price Statistics
The stock price has decreased by -22.94% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -22.94% |
| 50-Day Moving Average | 21.81 |
| 200-Day Moving Average | 24.81 |
| Relative Strength Index (RSI) | 46.03 |
| Average Volume (20 Days) | 1,243,302 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603205 had revenue of CNY 1.05 billion and earned 113.75 million in profits. Earnings per share was 0.72.
| Revenue | 1.05B |
| Gross Profit | 254.44M |
| Operating Income | 134.93M |
| Pretax Income | 128.85M |
| Net Income | 113.75M |
| EBITDA | 179.19M |
| EBIT | 134.93M |
| Earnings Per Share (EPS) | 0.72 |
Balance Sheet
The company has 799.38 million in cash and 18.18 million in debt, with a net cash position of 781.20 million or 5.01 per share.
| Cash & Cash Equivalents | 799.38M |
| Total Debt | 18.18M |
| Net Cash | 781.20M |
| Net Cash Per Share | 5.01 |
| Equity (Book Value) | 1.51B |
| Book Value Per Share | 9.67 |
| Working Capital | 1.01B |
Cash Flow
In the last 12 months, operating cash flow was 162.83 million and capital expenditures -91.05 million, giving a free cash flow of 71.78 million.
| Operating Cash Flow | 162.83M |
| Capital Expenditures | -91.05M |
| Depreciation & Amortization | 44.26M |
| Net Borrowing | -3.05M |
| Free Cash Flow | 71.78M |
| FCF Per Share | 0.46 |
Margins
Gross margin is 24.20%, with operating and profit margins of 12.83% and 10.82%.
| Gross Margin | 24.20% |
| Operating Margin | 12.83% |
| Pretax Margin | 12.26% |
| Profit Margin | 10.82% |
| EBITDA Margin | 17.04% |
| EBIT Margin | 12.83% |
| FCF Margin | 6.83% |
Dividends & Yields
This stock pays an annual dividend of 0.25, which amounts to a dividend yield of 1.15%.
| Dividend Per Share | 0.25 |
| Dividend Yield | 1.15% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 37.03% |
| FCF Payout Ratio | 54.33% |
| Buyback Yield | -26.09% |
| Shareholder Yield | -24.94% |
| Earnings Yield | 3.35% |
| FCF Yield | 2.12% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 9, 2025. It was a forward split with a ratio of 1.3.
| Last Split Date | Jul 9, 2025 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
SHA:603205 has an Altman Z-Score of 11.94 and a Piotroski F-Score of 5.
| Altman Z-Score | 11.94 |
| Piotroski F-Score | 5 |